Biology of the multidrug resistance-associated protein, MRP
References (188)
- et al.
Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy
Adv Pharmacol
(1990) Bacterial periplasmic permeases as model systems for the superfamily of traffic ATPases, including the multidrug resistance protein and the cystic fibrosis transmembrane conductance regulator
Int Rev Cytol
(1992)- et al.
Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells
Blood
(1994) - et al.
P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines
Biochem Biophys Acta
(1992) - et al.
Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
Cell
(1993) - et al.
Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance
J Biol Chem
(1994) - et al.
Heavy metal resistance: a new role for P-glycoproteins in Leishmania
J Biol Chem
(1991) - et al.
A yeast metal resistance protein similar to human cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance-associated protein
J Biol Chem
(1994) Mechanisms of membrane protein turnover
Biochem Biophys Acta
(1990)- et al.
The products of the mdr1a and mdr1b genes from multidrug resistant murine cells have similar degradation rates
Life Sci
(1990)
Biosynthesis, processing and half-life of P-glycoprotein in a human multidrug-resistant KB cells
Biochem Biophys Acta
(1989)
Intracellular turnover of cystic fibrosis transmembrane conductance regulator—inefficient processing and rapid degradation of wild-type and mutant proteins
J Biol Chem
(1994)
Degradation of CFTR by the ubiquitin-proteasome pathway
Cell
(1995)
Phosphorylation of the cystic fibrosis transmembrane conductance regulator
J Biol Chem
(1992)
Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C
J Biol Chem
(1993)
Identification of the major phosphorylation domain of murine mdr1b P-glycoprotein analysis of the protein kinase A and protein kinase C phosphorylation sites
J Biol Chem
(1993)
Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications
Lancet
(1994)
The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates
J Biol Chem
(1994)
Cysteinyl leukotrienes in asthma: old mediators up to new tricks
Trends Pharmacol Sci
(1995)
Glutathione-associated cisdiamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells
J Biol Chem
(1993)
The role of the canalicular multispecific organic anion transporter in the disposal of endoand xenobiotics
Pharmacol Ther
(1994)
ATP-dependent S-(2,4-dinitrophenyl)glutathione transport in canalicular plasma membrane vesicles from rat liver
J Biol Chem
(1991)
ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membranes
J Biol Chem
(1990)
ATP/Mg2+-dependent cardiac transport system for glutathione S-conjugates—a study using rat heart sarcolemma vesicles
J Biol Chem
(1989)
The uncoupling of biliary lipid from bile acid secretion by organic anions in the rat
Gastroenterology
(1990)
Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
Biochem Biophys Acta
(1995)
Functional expression of the multidrug resistance-associated protein (MRP) in the yeast Saccharomyces cerevisiae
J Biol Chem
(1996)
Cystic fibrosis transmembrane conductance regulator is required for protein kinase A activation of an outwardly rectified anion channel purified from bovine tracheal epithelia
J Biol Chem
(1995)
Multidrug resistance in human lung cancer and topoisomerase II
Biochemistry of multidrug resistance mediated by the multidrug transporter
Annu Rev Biochem
(1993)
The 1991 Merck Frosst award. Multidrug resistance in small cell lung cancer
Can J Physiol Pharmacol
(1992)
The biochemistry of P-glycoproteinmediated multidrug resistance
Annu Rev Biochem
(1989)
Drug resistance and lung cancer
Expression of a full-length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin, and vinblastine
Isolation and expression of a complementary DNA that confers multidrug resistance
Nature
(1986)
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines
Nature
(1985)
Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA
Cancer Res
(1990)
Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
Science
(1992)
Multidrug resistance-associated protein: sequence correction
Science
(1993)
Overexpression of multidrug resistanceassociated protein (MRP) increases resistance to natural product drugs
Cancer Res
(1994)
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump
Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene
Cancer Res
(1994)
Multidrug resistance associated with Overexpression of MRP
ABC transporters: from microorganisms to man
Annu Rev Cell Biol
(1992)
Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells
Cancer Res
(1994)
Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport
Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells
Cancer Res
(1995)
Expression of multidrug resistance-associated protein (MRP), MDR1, and DNA Topoisomerase II in human multidrug-resistant bladder cancer cell lines
Br J Cancer
(1995)
Multidrug resistance (mdr) genes in human cancer
Br J Cancer
(1991)
Multidrug resistance
Annu Rev Med
(1991)
Cited by (409)
Oxaliplatin and irinotecan induce heterogenous changes in the EMT markers of metastasizing colorectal carcinoma cells
2018, Experimental Cell ResearchCitation Excerpt :Chemoresistance of malignant tumor cells is a recognized fact, with multiple contributing factors that could be grouped into several classes traditionally viewed as instrinsic (drug-independent) and acquired (drug-dependent) [3]. Drug-dependent mechanisms comprise overexpression of ATP-binding cassette (ABC) transmembrane transporters such as P-glycoprotein, organic cation transporters 1,2,3, copper efflux transporters, P-type ATPases – ATP7A and ATP7B and multidrug resistance-associated protein (MRP), which actively transport chemotherapy agents out of the cell [15,16]. Several published studies further brought evidence of chemotherapy resistance in cancer cells with upregulated EMT markers in gastrointestinal malignancies [17,18].
Sterically stabilized polymeric nanoparticles with a combinatorial approach for multi drug resistant cancer: In vitro and in vivo investigations
2014, International Journal of PharmaceuticsTargeted nanoparticles for simultaneous delivery of chemotherapeutic and hyperthermia agents - An in vitro study
2014, Journal of Photochemistry and Photobiology B: BiologyNatural and Acquired Resistance to Cancer Therapies
2015, The Molecular Basis of Cancer: Fourth EditionEmerging roles of ncRNAs regulating ABCC1 on chemotherapy resistance of cancer–a review
2024, Journal of ChemotherapyRole of <sup>99m</sup>Tc‑sestamibi Scintimammography in Predicting Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Prospective Study
2023, Indian Journal of Nuclear Medicine
Copyright © 1996 Published by Elsevier Ltd.